Emtricitabine and Tenofovir Disoproxil Fumarate
- Product NDC
- 71335-1844
- 11-digit product format
- 713351844
- Labeler code
- 71335
- Product ID
- 71335-1844_2ec19e4e-6ab0-44d3-ba36-1744a9197a85
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Emtricitabine and Tenofovir Disoproxil Fumarate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA090513
- Marketing category
- ANDA
- Marketing start
- 2021-03-10
- Marketing end
- 0000-00-00
- Substance
- EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- Active strength
- 200 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1844-1 | 71335184401 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-1844-1) | 2021-04-29 | 0000-00-00 | No | No | Current |
| 71335-1844-2 | 71335184402 | 3 TABLET, FILM COATED in 1 BOTTLE (71335-1844-2) | 2021-04-29 | 0000-00-00 | No | No | Current |